会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • AN ANTIPERSPIRANT COMPOSITION COMPRISING REACTIVE SALTS
    • WO2020187686A1
    • 2020-09-24
    • PCT/EP2020/056651
    • 2020-03-12
    • UNILEVER N.V.UNILEVER PLCCONOPCO, INC., D/B/A UNILEVER
    • LIU, RenjiangLI, XiaokeLIU, WeiningZHOU, Huanjun
    • A61Q15/00A61K8/19A61K8/24A61K8/27A61K8/28A61K8/365
    • The present invention is in the field of antiperspirant compositions, in particular, compositions comprising antiperspirant actives. Disclosed is an aqueous antiperspirant composition having pH 2 to 5, comprising: (i) a water-soluble phosphate salt; (ii) a water-soluble non-phosphate salt; and, (iii) a retarding agent; wherein said water-soluble phosphate salt is selected from monosodium phosphate, disodium phosphate, trisodium phosphate, monopotassium phosphate, dipotassium phosphate, tripotassium phosphate, monoammonium phosphate, diammonium phosphate, triammonium phosphate, lithium dihydrogen phosphate, dilithium hydrogen phosphate and lithium phosphate; wherein said water-soluble non-phosphate salt is selected from calcium chloride, calcium gluconate, calcium nitrate, calcium bromide, calcium formate, calcium lactate, calcium propanoate, calcium acetate, calcium dobesilate, magnesium chloride, magnesium nitrate, magnesium sulphate, magnesium citrate, magnesium gluconate, magnesium acetate, magnesium lactate, magnesium malate, ferric chloride, ferric nitrate, ferric sulphate, zinc chloride, zinc nitrate, zinc citrate, zinc sulphate, zinc gluconate, copper chloride, copper sulphate, copper nitrate, copper(II) acetate, copper(II) gluconate, iron(III) citrate, zirconium nitrate, zirconium tetrachloride, zirconium oxychloride, strontium chloride, strontium nitrate, barium chloride, barium nitrate, lanthanum chloride, lanthanum acetate, Tin(II) chloride, Tin (IV) chloride, and silver nitrate; wherein said retarding agent is a compound which comprises at least one functional group selected from -COOH, -COO - , -SO 3 H or -SO 3 - ; wherein said composition is not a dentifrice; wherein said water-soluble phosphate salt, water-soluble non-phosphate salt and retarding agent are present in one phase; wherein the solubility of said salt in water is assessed at 25°C and atmospheric pressure.
    • 10. 发明申请
    • ORAL CARE COMPOSITION
    • WO2020099068A1
    • 2020-05-22
    • PCT/EP2019/078507
    • 2019-10-21
    • UNILEVER N.V.UNILEVER PLCCONOPCO, INC., D/B/A UNILEVER
    • WANG, XiaohongZHANG, MeiliZHOU, Huanjun
    • A61K8/24A61Q11/00A61K8/19
    • An oral care composition is disclosed comprising from 0.25 to 60% by weight of composite particles, from 0.1 to 20% by weight of a water soluble calcium source and a physiologically acceptable carrier, wherein the composite particle comprises a first component core comprising a water insoluble and/or slightly soluble calcium source, and a second component coating comprising a biomineralization agent, wherein the water insoluble and/or slightly soluble calcium source comprises calcium carbonate, calcium aluminate, calcium oxalate, calcium oxide, calcium carboxymethyl cellulose, calcium alginate, calcium hydroxide, calcium sulfate, calcium salts of citric acid or mixtures thereof, wherein the biomineralization agent comprises amorphous calcium phosphate, α- tricalcium phosphate, β-tricalcium phosphate, calcium deficient hydroxyapatite (Ca 9 (HPO 4 )(PO 4 ) 5 OH), dicalcium phosphate (CaHPO 4 ), dicalcium phosphate dehydrate (CaHPO 4 ·2H 2 O), hydroxyapatite (Ca 10 (PO 4 ) 6 (OH) 2 ), octacalcium phosphate (Ca 8 H 2 (PO 4 ) 6 ·5H 2 O), tetracalcium phosphate (Ca 4 (PO 4 ) 2 O) or mixtures thereof, and wherein the composite particle has a specific surface area of from 15 m 2 /g to 200 m 2 /g, measured using nitrogen via the BET method according to ISO 9277.